How do you approach ADT and pelvic lymph node radiation in the salvage setting for patients with a PSA <0.5 ng/mL?
How do the results of RTOG 0534 presented at ASTRO affect your decision making?
Answer from: Radiation Oncologist at Community Practice
This is an important and timely question.As I have previously written on this forum, I highly recommend those interested in first reading https://www.ncbi.nlm.nih.gov/pubmed/30238901, which outlines those who should and shouldnt receive ADT with salvage RT. In general, those with PSA <0.5 should...
Comments
Radiation Oncologist at Prostate Cancer Center Of New Jersey Very well explained. Thanks
Radiation Oncologist at Tennessee Oncology Regarding the use of nodal RT, how should the time...
Radiation Oncologist at Radiant Oncology @Daniel E. Spratt: " However, those with PSA <0...
Radiation Oncologist at Case Western Reserve University/ University Hospitals Seidman Cancer Center It is not published yet. They did present the data...
Answer from: Radiation Oncologist at Community Practice
Axumin and PSMA scan will redefine how we treat in salvage setting. Lower salvage rate with higher PSA in previous studies could have been because we were treating the wrong target (prostatic bed) vs. recurrent nodal disease which were not picked up by conventional scan (Higher sensitivity of t...
Comments
Radiation Oncologist at Radiation Oncology of Atlanta Would the presence of high-risk features change yo...
Radiation Oncologist at Mount Sinai Medical Center Miami I am not a prostate expert, but I can't see how yo...
Radiation Oncologist at Case Western Reserve University/ University Hospitals Seidman Cancer Center Nicolas-
You have a commonly held viewpoint. I t...
Radiation Oncologist at The Oregon Clinic-Radiation Oncology West While randomized evidence should always guide disc...
Radiation Oncologist at Allentown Radiation Oncology Associates @Daniel E. Spratt - has the publication of RTOG 05...
Very well explained. Thanks
Regarding the use of nodal RT, how should the time...
@Daniel E. Spratt: " However, those with PSA <0...
It is not published yet. They did present the data...